These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 10570291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F, Bernheiden M, Menzel R, Witt S, Jack RS, Grunwald U, Fan X, Schütt C.
    Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
    J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
    [Abstract] [Full Text] [Related]

  • 6. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI, Orr SL, Lawson EM, Soldau K, Tobias PS.
    J Immunol; 1999 May 01; 162(9):5483-9. PubMed ID: 10228028
    [Abstract] [Full Text] [Related]

  • 7. LPS, recIL1 and smooth muscle cell-IL1 activate vascular cells by specific mechanisms.
    Loppnow H.
    Prog Clin Biol Res; 1994 May 01; 388():309-21. PubMed ID: 7530369
    [Abstract] [Full Text] [Related]

  • 8. Activation of endothelial cells by endotoxin: direct versus indirect pathways and the role of CD14.
    Pugin J, Ulevitch RJ, Tobias PS.
    Prog Clin Biol Res; 1995 May 01; 392():369-73. PubMed ID: 8524944
    [Abstract] [Full Text] [Related]

  • 9. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
    Haziot A, Rong GW, Silver J, Goyert SM.
    J Immunol; 1993 Aug 01; 151(3):1500-7. PubMed ID: 7687634
    [Abstract] [Full Text] [Related]

  • 10. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS, Brcic M, Franchini M, Jungi TW.
    Vet Immunol Immunopathol; 2007 Jul 15; 118(1-2):92-104. PubMed ID: 17559944
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay.
    Yu W, Soprana E, Cosentino G, Volta M, Lichenstein HS, Viale G, Vercelli D.
    J Immunol; 1998 Oct 15; 161(8):4244-51. PubMed ID: 9780199
    [Abstract] [Full Text] [Related]

  • 12. Moesin: a potential LPS receptor on human monocytes.
    Amar S, Oyaisu K, Li L, Van Dyke T.
    J Endotoxin Res; 2001 Oct 15; 7(4):281-6. PubMed ID: 11717582
    [Abstract] [Full Text] [Related]

  • 13. Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS.
    Bussolati B, David S, Cambi V, Tobias PS, Camussi G.
    Int J Mol Med; 2002 Oct 15; 10(4):441-9. PubMed ID: 12239591
    [Abstract] [Full Text] [Related]

  • 14. Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins.
    Bsibsi M, Bajramovic JJ, Van Duijvenvoorden E, Persoon C, Ravid R, Van Noort JM, Vogt MH.
    Glia; 2007 Apr 01; 55(5):473-82. PubMed ID: 17205552
    [Abstract] [Full Text] [Related]

  • 15. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression.
    Böcker U, Yezerskyy O, Feick P, Manigold T, Panja A, Kalina U, Herweck F, Rossol S, Singer MV.
    Int J Colorectal Dis; 2003 Jan 01; 18(1):25-32. PubMed ID: 12458377
    [Abstract] [Full Text] [Related]

  • 16. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system.
    Savedra R, Delude RL, Ingalls RR, Fenton MJ, Golenbock DT.
    J Immunol; 1996 Sep 15; 157(6):2549-54. PubMed ID: 8805656
    [Abstract] [Full Text] [Related]

  • 17. Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: implications for myeloid and nonmyeloid cell activation.
    Cunningham MD, Bajorath J, Somerville JE, Darveau RP.
    Clin Infect Dis; 1999 Mar 15; 28(3):497-504. PubMed ID: 10194067
    [Abstract] [Full Text] [Related]

  • 18. Functional analysis of recombinant bovine CD14.
    Wang Y, Zarlenga DS, Paape MJ, Dahl GE, Tomita GM.
    Vet Res; 2003 Mar 15; 34(4):413-21. PubMed ID: 12911858
    [Abstract] [Full Text] [Related]

  • 19. alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.
    Nita IM, Serapinas D, Janciauskiene SM.
    Int J Biochem Cell Biol; 2007 Mar 15; 39(6):1165-76. PubMed ID: 17448722
    [Abstract] [Full Text] [Related]

  • 20. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function.
    Grunwald U, Krüger C, Schütt C.
    Circ Shock; 1993 Mar 15; 39(3):220-5. PubMed ID: 7680967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.